Algert Global LLC Buys Shares of 13,216 Trupanion, Inc. (NASDAQ:TRUP)

Algert Global LLC acquired a new position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,216 shares of the financial services provider's stock, valued at approximately $637,000.

Several other large investors have also recently added to or reduced their stakes in TRUP. Freestone Grove Partners LP acquired a new stake in shares of Trupanion in the 4th quarter worth about $7,776,000. Baillie Gifford & Co. raised its holdings in shares of Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after buying an additional 147,341 shares during the last quarter. First Trust Advisors LP bought a new stake in Trupanion during the 4th quarter valued at $7,083,000. Dimensional Fund Advisors LP grew its stake in shares of Trupanion by 112.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after purchasing an additional 144,828 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Trupanion by 458.3% during the fourth quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider's stock valued at $7,620,000 after purchasing an additional 129,782 shares during the period.

Insiders Place Their Bets

In related news, SVP Emily Dreyer sold 14,025 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the transaction, the senior vice president now directly owns 27,645 shares of the company's stock, valued at approximately $895,974.45. The trade was a 33.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at approximately $3,728,629.76. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,792 shares of company stock worth $1,122,802. Corporate insiders own 5.50% of the company's stock.

Trupanion Price Performance

Shares of NASDAQ:TRUP traded up $0.14 on Wednesday, reaching $45.73. 404,596 shares of the company traded hands, compared to its average volume of 634,775. The stock has a market capitalization of $1.96 billion, a PE ratio of -198.83, a P/E/G ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The company's 50 day moving average is $37.18 and its 200-day moving average is $44.44. Trupanion, Inc. has a fifty-two week low of $25.90 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same period last year, the firm posted ($0.16) earnings per share. The firm's quarterly revenue was up 11.7% compared to the same quarter last year. As a group, analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Stifel Nicolaus cut their price objective on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Finally, Lake Street Capital lowered their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $51.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.